Cancer Chemotherapy and Pharmacology

, Volume 62, Issue 5, pp 867–873 | Cite as

Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals

  • Tomohiro Nabekura
  • Takeshi Yamaki
  • Kazuyuki Ueno
  • Shuji Kitagawa
Original Article

Abstract

Purpose

For the development of a safe and effective dual inhibitor of anticancer drug efflux transporters P-glycoprotein and multidrug resistance protein 1 (MRP1) to conquer multidrug resistance, we investigated the effects of dietary phytochemicals on the functions of P-glycoprotein and MRP1.

Methods

The effects of dietary phytochemicals on the functions of P-glycoprotein and MRP1 were investigated using P-glycoprotein-overexpressing human carcinoma KB-C2 cells and human MRP1 gene-transfected KB/MRP cells. The effects of natural compounds found in dietary supplements, herbs, and foods such as sesame, ginkgo, soybean, and licorice were evaluated.

Results

The accumulation of daunorubicin, a fluorescent substrate of P-glycoprotein, increased in the presence of sesamin, ginkgolic acid, matairesinol, glycyrrhetinic acid, glabridin, and phyllodulcin in KB-C2 cells. Glycyrrhetinic acid and matairesinol also increased the accumulation of calcein, a fluorescent substrate of MRP1, in KB/MRP cells. KB-C2 and KB/MRP cells were sensitized to anticancer drugs by glycyrrhetinic acid, showing that glycyrrhetinic acid reverses multidrug resistance. The verapamil-stimulated P-glycoprotein ATPase activity was inhibited by glycyrrhetinic acid. Glycyrrhetinic acid stimulated the ATPase activity of MRP1.

Conclusion

These results suggest that dietary phytochemicals, such as glycyrrhetinic acid found in licorice, have dual inhibitory effects on P-glycoprotein and MRP1 and might become useful to enhance the efficacy of cancer chemotherapy.

Keywords

P-glycoprotein MDR1 MRP1 ABC transporter Multidrug resistance Dietary phytochemical 

References

  1. 1.
    Allen JD, Brinkhuis RF, van Deemter L, Wijnholds J, Shinkel AH (2000) Extensive contribution of the multidrug transporters P-glycoprotein and MRP1 to basal drug resistance. Cancer Res 60:5761–5766PubMedGoogle Scholar
  2. 2.
    Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361–368PubMedCrossRefGoogle Scholar
  3. 3.
    Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF (2002) Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 302:645–650PubMedCrossRefGoogle Scholar
  4. 4.
    Bhathena SJ, Velasquez MT (2002) Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76:1191–1201PubMedGoogle Scholar
  5. 5.
    Hirose N, Inoue T, Nishihara K, Sugano M, Akimoto K, Shimizu S, Yamada H (1991) Inhibition of cholesterol absorption and synthesis in rats by sesamin. J Lipid Res 32:629–638PubMedGoogle Scholar
  6. 6.
    Jaggy H, Koch E (1997) Chemistry and biology of alkylphenols from Ginkgo biloba L. Pharmazie 52:735–738PubMedGoogle Scholar
  7. 7.
    Johnson WW (2004) ABC transporter proteins and cellular drug resistance: P-glycoprotein and analogous transporters. In: Lu DR, Øie S (eds) Cellular drug delivery: principles and practice. Humana Press, Totowa, pp. 129–162Google Scholar
  8. 8.
    Kitagawa S, Nabekura T, Kamiyama S (2004) Inhibition of P-glycoprotein function by tea catechins in KB-C2 cells. J Pharm Pharmacol 56:1001–1005PubMedCrossRefGoogle Scholar
  9. 9.
    Kitagawa S, Nabekura T, Kamiyama S, Takahashi T, Nakamura Y, Kashiwada Y, Ikeshiro Y (2005) Effects alkyl gallates on P-glycoprotein function. Biochem Pharmacol 70:1262–1266PubMedCrossRefGoogle Scholar
  10. 10.
    Kitagawa S, Nabekura T, Takahashi T, Nakamura Y, Sakamoto H, Tano H, Hirai M, Tsukahara G (2005) Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells. Biol Pharm Bull 28:2274–2278PubMedCrossRefGoogle Scholar
  11. 11.
    Leslie EM, Mao Q, Oleschuk CJ, Deeley RG, Cole SPC (2001) Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and ATPase activities by interaction with dietary flavonoids. Mol Pharmacol 59:1171–1180PubMedGoogle Scholar
  12. 12.
    Maclennan KM, Darlington CL, Smith PF (2002) The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 67:235–257PubMedCrossRefGoogle Scholar
  13. 13.
    Nabekura T, Kamiyama S, Kitagawa S (2005) Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem Biophys Res Commun 327:866–870PubMedCrossRefGoogle Scholar
  14. 14.
    Nagata K, Nishitani M, Matsuo M, Kioka M, Amachi T, Ueda K (2000) Nonequivalent nucleotide trapping in the two nucleotide binding folds of the human multidrug resistance protein MRP1. J Biol Chem 275:17626–17630PubMedCrossRefGoogle Scholar
  15. 15.
    Sarkadi B, Price EM, Boucher RC, Germann UA, Scarborough GA (1992) Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 267:4854–4858PubMedGoogle Scholar
  16. 16.
    Shibata S (2000) A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 120:849–862PubMedGoogle Scholar
  17. 17.
    Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234PubMedCrossRefGoogle Scholar
  18. 18.
    Taguchi Y, Yoshida A, Takada Y, Komano T, Ueda K (1997) Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP). FEBS Lett 401:11–14PubMedCrossRefGoogle Scholar
  19. 19.
    Tominaga H, Ishiyama M, Ohseto F, Sasamoto K, Hamamoto T, Suzuki K, Watanabe M (1999) A water-soluble tetrazolium salt useful for calorimetric cell viability assay. Anal Commun 36:47–50CrossRefGoogle Scholar
  20. 20.
    Wortelboer HM, Usta M, van Zanden JJ, van Bladeren PJ, Rietjens IMCM, Cnubben NHP (2005) Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of α,β-unsaturated carbonyl compounds. Biochem Pharmacol 69:1879–1890PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Tomohiro Nabekura
    • 1
  • Takeshi Yamaki
    • 1
  • Kazuyuki Ueno
    • 1
  • Shuji Kitagawa
    • 2
  1. 1.Faculty of Pharmaceutical SciencesNiigata University of Pharmacy and Applied Life SciencesNiigataJapan
  2. 2.Kobe Pharmaceutical UniversityKobeJapan

Personalised recommendations